ZY8-33363-29144
5 vaccinations
8 coded responses
51 check-ins
8 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 443 / OH
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-14
Dose 1 — Pfizer-BioNTech
-
2021-03-16
Registered in v-safe
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-17
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: Swollen glandMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Joint pains, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to workAdult check-in
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-28
-
2021-04-06
Dose 2 — Pfizer-BioNTech
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-22
- 2021-04-27
-
2021-05-06
Survey response — day 28, dose 2MedDRA: Arthralgia, Pain, Pre-existing disease — Feeling: Fair · Be unable to workFree text: Joint and body aches but I believe are from autoimmune flareMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-11
- 2021-05-18
-
2021-07-06
Survey response — 3 months, dose 2MedDRA: Colitis, Inflammation — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Inflammation in codon and small intestine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-06
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-09
- 2021-10-05
-
2021-10-06
Dose 3 — Pfizer-BioNTech
- 2021-10-06
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-13
- 2021-10-20
-
2021-10-28
Survey response — day 21, dose 3MedDRA: Headache, Oropharyngeal pain — Feeling: FairFree text: Sore throat and headacheMedDRA releases: 2024-11 · check-in free text available
- 2021-11-03
- 2021-11-11
- 2021-11-17
-
2022-01-05
Survey response — 3 months, dose 3MedDRA: Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Inconclusive mammogram. Have to go for an ultrasound and dx mammogram. Possible cysts. · Healthcare visit (other): MammogramMedDRA releases: 2024-11 · check-in free text available
-
2022-01-05
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-01-06
- 2022-04-09
-
2022-04-25
Dose 4 — Pfizer-BioNTech
- 2022-05-01
- 2022-05-04
- 2022-05-10
- 2022-05-16
- 2022-05-25
-
2022-05-30
Survey response — day 35, dose 4MedDRA: Lymphadenopathy — Feeling: FairFree text: Swollen glandsMedDRA releases: 2024-11 · check-in free text available
- 2022-06-06
-
2022-09-16
Dose 5 — Pfizer-BioNTech
- 2022-09-30
- 2022-10-07
-
2022-10-14
Survey response — day 28, dose 5MedDRA: Ageusia, Anosmia, Cough, Fatigue, Headache, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, fever, sore throat, fatigue, headache, lose of taste and smell. Positive Covid-19 testMedDRA releases: 2024-11 · check-in free text available
- 2022-10-21
-
2022-10-29
Survey response — day 42, dose 5MedDRA: Ageusia, Anosmia, Cough, Parosmia, Pyrexia — Feeling: FairFree text: Phantom smells, lose of smell and taste that returns and then leaves like a switch flipping on and off, sporadic fever - lingering mild coughMedDRA releases: 2024-11 · check-in free text available
- 2022-12-17
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-14 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
| 4 | 2022-04-25 | Pfizer-BioNTech | No |
| 5 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen gland
Release 8 — day 28, dose 2
Symptoms: Joint and body aches but I believe are from autoimmune flare
Release 9 — 3 months, dose 2
Symptoms: Inflammation in codon and small intestine.
Release 10 — day 21, dose 3
Symptoms: Sore throat and headache
Release 10 — 3 months, dose 3
Symptoms: Inconclusive mammogram. Have to go for an ultrasound and dx mammogram. Possible cysts.
Healthcare visit (other): Mammogram
Release 11 — day 35, dose 4
Symptoms: Swollen glands
Release 12 — day 28, dose 5
Symptoms: Cough, fever, sore throat, fatigue, headache, lose of taste and smell. Positive Covid-19 test
Release 12 — day 42, dose 5
Symptoms: Phantom smells, lose of smell and taste that returns and then leaves like a switch flipping on and off, sporadic fever - lingering mild cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Colitis | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release